Effect of recombinant human growth hormone in a postpediatric hemodialysis patient with delayed growth.
We present an 18-year-old patient who has been on renal replacement therapy since the age of 11. He had growth retardation and delayed puberty, with a bone age of 13.6 years. Treatment with human recombinant growth hormone (rhGH) resulted in a clearcut increase in height and lean body mass. We emphasize that rhGH treatment could be tried even at a postpediatric age, provided bone radiology suggests that further growth is possible.
Ortiz
A
A
Servicio de Nefrologia, Fundación Jiménez Díaz, Madrid, España.
Plácida Garrón
M
M
Rovira
A
A
Moliz
M
M
Banderas
M
M
Crespo
M
M
Sandiumenge
J
J
Hernando
L
L
Caramelo
C
C
D000293:Adolescent; D000367:Age Factors; D006130:Growth Disorders / Q000209:etiology / Q000628:therapy*; D013006:Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008297:Male; D011994:Recombinant Proteins; D006435:Renal Dialysis
D011994:Recombinant Proteins; D013006:Growth Hormone